Welcome to the Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.
Emerging technologies, the latest clinical applications, best practices, and more are waiting for you. The 2022 Virtual SNMMI Mid-Winter and ACNM Annual Meeting will feature three educational tracks highlighting the latest innovations and techniques in the field, including a dedicated track on cardiovascular nuclear medicine.
Unfortunately, the ongoing COVID-19 global pandemic and surging Omicron variant have forced us to cancel our planned in-person event in Orlando. We are excited to announce that a Virtual 2022 SNMMI Mid-Winter and ACNM Annual Meeting will now take place Friday, February 25 through Sunday, February 27, 2022. Read the full announcement.
Make your plans to attend the SNMMI Therapeutics Conference, in-person, March 10-12, 2022 at the Hyatt Regency New Orleans. This two-and-a-half-day event will explore the latest innovations and clinical applications in radiopharmaceutical therapy.
Early-bird registration deadline: Thursday, January 20, 2022
Make 2022 the year you take the next important step in your career path. Submit your abstract by Tuesday, January 11, 2022, for the opportunity to present and publish innovative scientific investigations to a global audience of medical imaging professionals at the SNMMI 2022 Annual Meeting, June 11-14, 2022 in Vancouver, BC, Canada.
Due to the surging Omicron variant, we have made the decision to provide you with more time to submit your abstract for the SNMMI 2022 Annual Meeting.
You now have until Tuesday, January 25, 2022, to submit your abstract for the opportunity to present your research in Vancouver or virtually.
New! Brain Imaging Tech TIME
The new Tech TIME (Technical Imaging Multidisciplinary Education) series has been created by the SNMMI Technologist Section to address the information gap between traditional continuing education and immediately available online reference materials. This series begins with brain imaging procedures in nuclear medicine and PET.
The goal of the Tech TIME is to provide you with accurate and up to date online tools to quickly solve questions and problems. These great resources will include easy-to-read fact sheets, 2-3 minute video vignettes to answer specific “how-to” questions, case studies with relevant patient examples, and a valuable directory for follow up-learning or continuing education credit.
Funded by a partnership grant from Eli Lilly & Company to create non-credit training/informational tools about PET brain imaging for technologists.
Re-focus with SNMMI's technologist-focused publications and enhance your nuclear medicine knowledge and comprehension.
Save 10% when you purchase Review of Nuclear Medicine Technology, 5th Edition, Practical Mathematics in Nuclear Medicine Technology, 2nd Edition, and the Quick Reference Protocol Manual for Nuclear Medicine Technologists together as part of this new Technologist Study and Reference Combo.
Save 10% when you purchase "Practical Mathematics in Nuc. Med. Technology - 2nd Ed." and "Basic Science of Nuclear Medicine: The Bare Bone Essentials" together as part of this new Technologist Math and Science combo. Purchase.
Save 10% when you purchase "Quick Reference Protocol Manual for NM Technologists" and "' Review of Nuclear Medicine Technology - 5th Ed" together as part of this new Technologist Reference and Review combo. Purchase.
Save 10% on the Review of Nuclear Medicine Technology and Practical Mathematics in Nuclear Medicine Technology when you purchase them together as part of the best-selling Technologist Study Combo. Purchase.
The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.
Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.
The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities. It may not cover all areas which may present themselves in actual practice. These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case. THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.
NMT Scope of Practice and Performance Standards - Approved May 2020
The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.
The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.
In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.
Research published in the January issue of JNM has confirmed the accuracy of the European Association of Urology risk classification system that groups prostate cancer patients based on their risk of recurrence.
On January 11, CMS announced that it proposes to cover FDA-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease under CED in CMS-approved randomized controlled trials. SNMMI reacts.
When assessed together in an AI model, coronary F-18 NaF uptake on PET and quantitative coronary plaque characteristics on CT angiography were found to provide risk prediction superior to that of clinical data alone.
SNMMI and peer medical groups have issued AUC for PSMA PET imaging. Published in the January issue of JNM, the criteria are the product of an international multidisciplinary panel of expert healthcare providers.
Emerging technologies, the latest clinical applications, best practices, and more are waiting for you. The 2022 SNMMI Mid-Winter and ACNM Annual Meeting will feature three educational tracks highlighting the latest innovations and techniques in the field, including a dedicated track on nuclear cardiology.